Charting Only, page-212

Hard to buy here on a double edged sword. A small SPP uptake will put another cap raise on the cards in the next few months as their cash burn is ridiculous. A large SPP uptake will result in some punters wanting to trade out for a 5% profit and I can't see buyers soaking up volume hence a further sell down, All I see is carnage on the horizon for CHM, they need a major cornerstone investor / donor imo and put funding questions away for 12 months while they continue R&D and clinical trials. 2 cents before Christmas imo